유전체학 시장의 성장은 어떤 요인에 의해 뒷받침되나요?

시장보고서

상품코드

1941492

유전체학 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 성과물별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Genomics Market Size, Share & Trends Analysis Report By Application (Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery), By Deliverables (Products, Services), By End-use, By Region, And Segment Forecasts, 2026 - 2033

발행일: 2026년 01월 | 리서치사:

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유전체학 시장 개요

세계의 유전체학 시장 규모는 2025년 217억 6,000만 달러로 추정되며, 2033년에 725억 달러에 이를 것으로 예측됩니다.

또한 2026-2033년에는 CAGR 18.2%를 나타낼 것으로 예측됩니다. 이러한 성장은 헬스케어, 산업 생명공학, 연구 분야에서 첨단 유전자 설계, 채널 엔지니어링, 데이터 기반 생물학적 혁신을 가능하게 하는 새로운 유전체학 응용기술에 의해 뒷받침되고 있습니다.

자주 묻는 질문

유전체학 시장의 규모는 어떻게 예측되나요?
- 2025년에는 217억 6,000만 달러, 2033년에는 725억 달러에 이를 것으로 예측됩니다. 예측기간 동안 CAGR은 18.2%가 될 것으로 전망됩니다.
유전체학 시장의 성장은 어떤 요인에 의해 뒷받침되나요?
- 헬스케어, 산업 생명공학, 연구 분야에서 첨단 유전자 설계, 채널 엔지니어링, 데이터 기반 생물학적 혁신을 가능하게 하는 새로운 유전체학 응용기술에 의해 뒷받침되고 있습니다.

The global genomics market size was estimated at USD 21.76 billion in 2025 and is projected to reach USD 72.50 billion by 2033, growing at a CAGR of 18.2% from 2026 to 2033. This growth is supported by emerging genomics applications, which enable advanced genetic design, pathway engineering, and data-driven biological innovation across healthcare, industrial biotechnology, and research applications.

Global Genomics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global genomics market report based on application, deliverables, end-use, and region.

Application Outlook (Revenue, USD Million, 2021 - 2033)
Functional Genomics
- Real-time PCR
- Transfection
- SNP Analysis
- Mutational Analysis
- Microarray Analysis
- RNA Interference
Epigenomics
- Bisulfite Sequencing
- Microarray Analysis
- Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
- Methylated DNA Immunoprecipitation (MeDIP)
- High Resolution Melt (HRM)
- Chromatin Accessibility Assays
Pathway Analysis
- Microarray Analysis
- Bead-based Analysis
- Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
- Real-time PCR
Biomarker Discovery
- DNA Sequencing
- Microarray Analysis
- Real-time PCR
- Mass Spectrometry
- Statistical Analysis
- Bioinformatics
Others
Deliverables Outlook (Revenue, USD Million, 2021 - 2033)
Products
- Instruments/Systems/Software
- Consumables & Reagents
Services
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
- Others
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical and Biotechnology Companies
Hospitals and Clinics
Academic and Government Institutes
Clinical Research
Other End Users
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwaita

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Application Segment
- 1.2.2. Deliverables Segment
- 1.2.3. End Use Segment
1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Rapid Technological Advancements
- 3.3.2. Precision Medicine & Personalized Healthcare
3.4. Market Restraint Analysis
- 3.4.1. High Cost of Genomics Technologies
3.5. Industry Analysis Tools
- 3.5.1. PESTLE Analysis
- 3.5.2. Porter's Five Forces Analysis

Chapter 4. Application Business Analysis

4.1. Application Segment Dashboard
4.2. Global Genomics Market: Application Movement Analysis
4.3. Global Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
4.4. Functional Genomics
- 4.4.1. Functional Genomics Market, 2021 - 2033 (USD Million)
- 4.4.2. Real-time PCR
  - 4.4.2.1. Real-time PCR Market, 2021 - 2033 (USD Million)
- 4.4.3. Transfection
  - 4.4.3.1. Transfection Market, 2021 - 2033 (USD Million)
- 4.4.4. SNP Analysis
  - 4.4.4.1. SNP Analysis Market, 2021 - 2033 (USD Million)
- 4.4.5. Mutational Analysis
  - 4.4.5.1. Mutational Analysis Market, 2021 - 2033 (USD Million)
- 4.4.6. Microarray Analysis
  - 4.4.6.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
- 4.4.7. RNA Interference
  - 4.4.7.1. RNA Interference Market, 2021 - 2033 (USD Million)
4.5. Epigenomics
- 4.5.1. Epigenomics Market, 2021 - 2033 (USD Million)
- 4.5.2. Bisulfite Sequencing
  - 4.5.2.1. Bisulfite Sequencing Market, 2021 - 2033 (USD Million)
- 4.5.3. Microarray Analysis
  - 4.5.3.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
- 4.5.4. Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
  - 4.5.4.1. Chromatin Immunoprecipitation (ChIP & ChIP-Seq) Market, 2021 - 2033 (USD Million)
- 4.5.5. Methylated DNA Immunoprecipitation (MeDIP)
  - 4.5.5.1. Methylated DNA Immunoprecipitation (MeDIP) Market, 2021 - 2033 (USD Million)
- 4.5.6. High Resolution Melt (HRM)
  - 4.5.6.1. High Resolution Melt (HRM) Market, 2021 - 2033 (USD Million)
- 4.5.7. Chromatin Accessibility Assays
  - 4.5.7.1. Chromatin Accessibility Assays Market, 2021 - 2033 (USD Million)
4.6. Pathway Analysis
- 4.6.1. Pathway Analysis Market, 2021 - 2033 (USD Million)
- 4.6.2. Microarray Analysis
  - 4.6.2.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
- 4.6.3. Bead-based Analysis
  - 4.6.3.1. Bead-based Analysis Market, 2021 - 2033 (USD Million)
- 4.6.4. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
  - 4.6.4.1. Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Market, 2021 - 2033 (USD Million)
- 4.6.5. Real-time PCR
  - 4.6.5.1. Real-time PCR Market, 2021 - 2033 (USD Million)
4.7. Biomarker Discovery
- 4.7.1. Biomarker Discovery Market, 2021 - 2033 (USD Million)
- 4.7.2. DNA Sequencing
  - 4.7.2.1. DNA Sequencing Market, 2021 - 2033 (USD Million)
- 4.7.3. Microarray Analysis
  - 4.7.3.1. Microarray Analysis Market, 2021 - 2033 (USD Million)
- 4.7.4. Real-time PCR
  - 4.7.4.1. Real-time PCR Market, 2021 - 2033 (USD Million)
- 4.7.5. Mass Spectrometry
  - 4.7.5.1. Mass Spectrometry Market, 2021 - 2033 (USD Million)
- 4.7.6. Statistical Analysis
  - 4.7.6.1. Statistical Analysis Market, 2021 - 2033 (USD Million)
- 4.7.7. Bioinformatics
  - 4.7.7.1. Bioinformatics Market, 2021 - 2033 (USD Million)
4.8. Others
- 4.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Deliverables Business Analysis

5.1. Deliverables Segment Dashboard
5.2. Global Genomics Market: Deliverables Movement Analysis
5.3. Global Genomics Market Size & Trend Analysis, by Deliverables, 2021 to 2033 (USD Million)
5.4. Products
- 5.4.1. Products Market, 2021 - 2033 (USD Million)
- 5.4.2. Instruments/Systems/Software
  - 5.4.2.1. Instruments/Systems/Software Market, 2021 - 2033 (USD Million)
- 5.4.3. Consumables & Reagents
  - 5.4.3.1. Consumables & Reagents Market, 2021 - 2033 (USD Million)
5.5. Services
- 5.5.1. Services Market, 2021 - 2033 (USD Million)
- 5.5.2. NGS-based Services
  - 5.5.2.1. NGS-based Services Market, 2021 - 2033 (USD Million)
- 5.5.3. Core Genomics Services
  - 5.5.3.1. Core Genomics Services Market, 2021 - 2033 (USD Million)
- 5.5.4. Biomarker Translation Services
  - 5.5.4.1. Biomarker Translation Services Market, 2021 - 2033 (USD Million)
- 5.5.5. Computational Services
  - 5.5.5.1. Computational Services Market, 2021 - 2033 (USD Million)
- 5.5.6. Others
  - 5.5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

6.1. End Use Segment Dashboard
6.2. Global Genomics Market: End Use Movement Analysis
6.3. Global Genomics Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical and Biotechnology Companies
- 6.4.1. Pharmaceutical and Biotechnology Companies Market, 2021 - 2033 (USD Million)
6.5. Hospitals and Clinics
- 6.5.1. Hospitals and Clinics Market, 2021 - 2033 (USD Million)
6.6. Academic and Government Institutes
- 6.6.1. Academic and Government Institutes Market, 2021 - 2033 (USD Million)
6.7. Clinical Research
- 6.7.1. Clinical Research Market, 2021 - 2033 (USD Million)
6.8. Others
- 6.8.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

7.1. Regional Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
7.3. North America
- 7.3.1. North America Genomics Market, 2021 - 2033 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key Country Dynamics
  - 7.3.2.2. Competitive Scenario
  - 7.3.2.3. Regulatory Framework
  - 7.3.2.4. U.S. Genomics Market, 2021 - 2033 (USD MILLION)
- 7.3.3. Canada
  - 7.3.3.1. Key Country Dynamics
  - 7.3.3.2. Competitive Scenario
  - 7.3.3.3. Regulatory Framework
  - 7.3.3.4. Canada Genomics Market, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key Country Dynamics
  - 7.3.4.2. Competitive Scenario
  - 7.3.4.3. Regulatory Framework
  - 7.3.4.4. Mexico Genomics Market, 2021 - 2033 (USD Million)
7.4. Europe
- 7.4.1. Europe Genomics Market, 2021 - 2033 (USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Competitive Scenario
  - 7.4.2.3. Regulatory Framework
  - 7.4.2.4. Germany Genomics Market, 2021 - 2033 (USD Million)
- 7.4.3. UK
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Competitive Scenario
  - 7.4.3.3. Regulatory Framework
  - 7.4.3.4. UK Genomics Market, 2021 - 2033 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Competitive Scenario
  - 7.4.4.3. Regulatory Framework
  - 7.4.4.4. France Genomics Market, 2021 - 2033 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key Country Dynamics
  - 7.4.5.2. Competitive Scenario
  - 7.4.5.3. Regulatory Framework
  - 7.4.5.4. Italy Genomics Market, 2021 - 2033 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key Country Dynamics
  - 7.4.6.2. Competitive Scenario
  - 7.4.6.3. Regulatory Framework
  - 7.4.6.4. Spain Genomics Market, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
  - 7.4.7.1. Key Country Dynamics
  - 7.4.7.2. Competitive Scenario
  - 7.4.7.3. Regulatory Framework
  - 7.4.7.4. Denmark Genomics Market, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
  - 7.4.8.1. Key Country Dynamics
  - 7.4.8.2. Competitive Scenario
  - 7.4.8.3. Regulatory Framework
  - 7.4.8.4. Sweden Genomics Market, 2021 - 2033 (USD Million)
- 7.4.9. Norway
  - 7.4.9.1. Key Country Dynamics
  - 7.4.9.2. Competitive Scenario
  - 7.4.9.3. Regulatory Framework
  - 7.4.9.4. Norway Genomics Market, 2021 - 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Asia Pacific Genomics Market, 2021 - 2033 (USD Million)
- 7.5.2. Japan
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Competitive Scenario
  - 7.5.2.3. Regulatory Framework
  - 7.5.2.4. Japan Genomics Market, 2021 - 2033 (USD Million)
- 7.5.3. China
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Competitive Scenario
  - 7.5.3.3. Regulatory Framework
  - 7.5.3.4. China Genomics Market, 2021 - 2033 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Competitive Scenario
  - 7.5.4.3. Regulatory Framework
  - 7.5.4.4. India Genomics Market, 2021 - 2033 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Competitive Scenario
  - 7.5.5.3. Regulatory Framework
  - 7.5.5.4. South Korea Genomics Market, 2021 - 2033 (USD Million)
- 7.5.6. Australia
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Competitive Scenario
  - 7.5.6.3. Regulatory Framework
  - 7.5.6.4. Australia Genomics Market, 2021 - 2033 (USD Million)
- 7.5.7. Thailand
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Competitive Scenario
  - 7.5.7.3. Regulatory Framework
  - 7.5.7.4. Thailand Genomics Market, 2021 - 2033 (USD Million)
7.6. Latin America
- 7.6.1. Latin America Genomics Market, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Competitive Scenario
  - 7.6.2.3. Regulatory Framework
  - 7.6.2.4. Brazil Genomics Market, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Competitive Scenario
  - 7.6.3.3. Regulatory Framework
  - 7.6.3.4. Argentina Genomics Market, 2021 - 2033 (USD Million)
7.7. MEA
- 7.7.1. MEA Genomics Market, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Competitive Scenario
  - 7.7.2.3. Regulatory Framework
  - 7.7.2.4. South Africa Genomics Market, 2021 - 2033 (USD Million)
- 7.7.3. Saudi Arabia
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Competitive Scenario
  - 7.7.3.3. Regulatory Framework
  - 7.7.3.4. Saudi Arabia Genomics Market, 2021 - 2033 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Competitive Scenario
  - 7.7.4.3. Regulatory Framework
  - 7.7.4.4. UAE Genomics Market, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Competitive Scenario
  - 7.7.5.3. Regulatory Framework
  - 7.7.5.4. Kuwait Genomics Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Participant's Overview
- 8.4.1. Illumina, Inc.
  - 8.4.1.1. Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
  - 8.4.2.1. Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Danaher Corporation
  - 8.4.3.1. Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. F. Hoffmann-La Roche Ltd.
  - 8.4.4.1. Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Agilent Technologies
  - 8.4.5.1. Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. BGI Genomics
  - 8.4.6.1. Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. QIAGEN N.V.
  - 8.4.7.1. Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. Oxford Nanopore Technologies
  - 8.4.8.1. Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. PacBio.
  - 8.4.9.1. Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Bio-Rad Laboratories, Inc.
  - 8.4.10.1. Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

유전체학 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 성과물별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Genomics Market Size, Share & Trends Analysis Report By Application (Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery), By Deliverables (Products, Services), By End-use, By Region, And Segment Forecasts, 2026 - 2033

유전체학 시장 개요

자주 묻는 질문

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수, 동향, 범위

제4장 용도별 비즈니스 분석

제5장 성과물 별 비즈니스 분석

제6장 최종 용도별 비즈니스 분석

제7장 지역별 비즈니스 분석

제8장 경쟁 구도

Genomics Market Summary

Table of Contents